A Trial to Learn How REGN5381 Works and How Safe it is in Adults With Heart Failure With Reduced Ejection Fraction (HFrEF)
Conditions: Heart Failure Interventions: Drug: REGN5381; Drug: Placebo Sponsors: Regeneron Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Heart | Heart Failure | Learning | Research | Universities & Medical Training